Literature DB >> 7908370

Results of adjuvant interferon study in WHO melanoma programme.

N Cascinelli, R Bufalino, A Morabito, R Mackie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7908370     DOI： 10.1016/s0140-6736(94)90030-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

Review 1.  Preventing relapse in melanoma.

Authors:  J Stebbing; M Gore
Journal:  Curr Oncol Rep       Date:  2000-05       Impact factor: 5.075

Review 2.  Adjuvant Therapy for Melanoma.

Authors:  Aya Agha; Ahmad A Tarhini
Journal:  Curr Oncol Rep       Date:  2017-05       Impact factor: 5.075

Review 3.  Adjuvant therapy for melanoma: How should we respond to high-dose interferon?

Authors:  P G de Takats; M V Williams; R Hawkins
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

Review 4.  Potential uses of interferon alpha 2 as adjuvant therapy in cancer.

Authors:  S S Agarwala; J M Kirkwood
Journal:  Ann Surg Oncol       Date:  1995-07       Impact factor: 5.344

Review 5.  Current treatment options for malignant melanoma.

Authors:  G L Cohen; C I Falkson
Journal:  Drugs       Date:  1998-06       Impact factor: 9.546

Review 6.  Is there a role for adjuvant high-dose interferon-alpha-2b in the management of melanoma?

Authors:  Michael S Sabel; Vernon K Sondak
Journal:  Drugs       Date:  2003       Impact factor: 9.546

7.  Cell-free tumor antigen peptide-based cancer vaccines.

Authors:  W Schmidt; M Buschle; W Zauner; H Kirlappos; K Mechtler; B Trska; M L Birnstiel
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

8.  Essential drugs for cancer chemotherapy. WHO consultation.

Authors: 
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

9.  Adjuvant therapy: melanoma.

Authors:  Diwakar Davar; Ahmad Tarhini; John M Kirkwood
Journal:  J Skin Cancer       Date:  2011-12-19

Review 10.  Early stage (I, II, III) melanoma.

Authors:  V K Sondak; M I Ross; L M Schuchter
Journal:  Curr Treat Options Oncol       Date:  2001-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.